Related Experiment Videos
Methodology of a controlled clinical study for cerebral aging evaluation.
G P Vecchi1, M Neri, C Cortelloni
1Institute of Gerontology and Geriatrics, University of Modena, Italy.
International Journal of Clinical Pharmacology Research
|January 1, 1990
Summary
Acetyl-L-carnitine effectively improved cognitive function in elderly patients experiencing cerebral aging. This treatment demonstrated significant benefits over placebo in a multicentre trial.
Area of Science:
- Gerontology
- Neuroscience
- Pharmacology
Background:
- Cerebral aging affects cognitive function in the elderly.
- Acetyl-L-carnitine is being investigated for its potential neuroprotective effects.
Purpose of the Study:
- To evaluate the efficacy of acetyl-L-carnitine in treating cerebral aging.
- To assess cognitive improvements in elderly patients receiving the treatment.
Main Methods:
- A multicentre, randomized, placebo-controlled trial involving 400 elderly patients (60-80 years).
- A 150-day treatment protocol with four phases, including placebo and acetyl-L-carnitine (1500 mg/day) periods.
- Psychometric testing was used for baseline, interim, and final assessments.
Main Results:
- Acetyl-L-carnitine treatment showed significant improvements in cognitive function compared to placebo.
- The study design allowed for evaluation of placebo effects and residual treatment benefits.
Conclusions:
- Acetyl-L-carnitine is an effective treatment for improving cognitive function in individuals with cerebral aging.
- The findings support the use of acetyl-L-carnitine for managing age-related cognitive decline.